Aptose Biosciences (APS) Insider Trading & Ownership → Bigger Than NVIDIA? (From Behind the Markets) (Ad) Free APS Stock Alerts C$1.18 -0.03 (-2.48%) (As of 03:59 PM ET) Add Compare Share Share Insider TradesStock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades Aptose Biosciences (TSE:APS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage19.07%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)C$70,065.19Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)C$63,848.40 Get APS Insider Trade Alerts Want to know when executives and insiders are buying or selling Aptose Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address APS Insider Buying and Selling by Quarter Ad Behind the MarketsThis Weight Loss Company Can't Make Enough ProductA tiny pharmaceutical company is getting overwhelmed by a massive demand for its new weight loss marvel. They recently reported over 25,000 Americans are starting their drug each week - a 4X increase since December!Get the name of the company and their stock ticker here >>> Aptose Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/19/2022William Glenn RiceDirectorBuy5,700C$0.88C$5,025.046/6/2022William Glenn RiceDirectorBuy2,776C$1.22C$3,375.6912/20/2021Denis BurgerDirectorBuy10,000C$1.87C$18,692.1012/16/2021William Glenn RiceDirectorBuy3,183C$1.92C$6,111.3611/26/2021William Glenn RiceDirectorBuy1,000C$3.07C$3,069.0011/19/2021Rafael BejarSenior OfficerBuy10,000C$3.38C$33,792.006/21/2021Warren WhiteheadDirectorSell15,400C$4.15C$63,848.40 (Data available from 1/1/2013 forward) APS Insider Trading Activity - Frequently Asked Questions Who is on Aptose Biosciences's Insider Roster? The list of insiders at Aptose Biosciences includes Denis Burger, Rafael Bejar, Warren Whitehead, and William Glenn Rice. Learn more on insiders at APS. What percentage of Aptose Biosciences stock is owned by insiders? 19.07% of Aptose Biosciences stock is owned by insiders. Learn more on APS's insider holdings. Which Aptose Biosciences insiders have been buying company stock? The following insider purchased APS shares in the last 24 months: William Glenn Rice (C$5,025.04). How much insider buying is happening at Aptose Biosciences? Insiders have purchased a total of 5,700 APS shares in the last 24 months for a total of C$5,025.04 bought. More Insider Trading Tools from MarketBeat Related Companies: Theratechnologies Insider Ownership ProMIS Neurosciences Insider Ownership Small Pharma Insider Ownership Microbix Biosystems Insider Ownership Antibe Therapeutics Insider Ownership Resverlogix Insider Ownership Hemostemix Insider Ownership Quest PharmaTech Insider Ownership Innovotech Insider Ownership Solarvest BioEnergy Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The Top 3 Stocks Sold by Insiders This QuarterTop 4 Stocks With Notable Insider Buying3 Small Cap Tech Stocks That Insiders Are Buying3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks This page (TSE:APS) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine...InvestorPlace | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptose Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptose Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.